powered by

Light chain amyloidosis

Chapter 3

In this chapter we can see some insights about systemic light chain (AL) amyloidosis with focus on the main clinical characteristics and on the pathway to correct diagnosis. The disease is rapidly progressive, and it is still diagnosed late, since most of the symptoms and clinical manifestations are nonspecific. Heart is one of the major organs affected, so cardiologists play an important role in early recognition of the disease. The diagnosis of AL amyloidosis needs to be biopsy proven. Identify the type of amyloid fibril is critical to avoid misdiagnosis and beginning of inappropriate treatment.

3 video contents

Category

Cardiology

Year

2023
  • AstraZeneca has provided a sponsorship grant towards this independent Programme

Video1:
21m 36s

Multiple myeloma and dysproteinemia: pearls for cardiologists

Roberta Mussinelli, MD, PhD - Pavia (Italy)

Video2:
21m 36s

Symptoms and signs of AL amyloidosis

Roberta Mussinelli, MD, PhD - Pavia (Italy)

Video3:
21m 36s

Diagnosis of AL amyloidosis

Roberta Mussinelli, MD, PhD - Pavia (Italy)

Contributor

Roberta Mussinelli

Foundation IRCCS Policlinico San Matteo, Pavia